NCC, BD to implement cervical cancer early detection program for underserved women in Peru

The National Cancer Coalition (NCC) and BD (Becton, Dickinson and Company), a leading global medical technology company, are pleased to announce the implementation of a cervical cancer early detection program to benefit 75,000 underserved women in Peru.  With a goal to reduce the high cervical cancer mortality levels in the mountainous region surrounding Cusco, this extensive three-year program is set to conduct liquid-based cytology exams utilizing the BD SurePath™ Liquid-based Pap Test System.  

National Cancer Coalition's President Robert Landry stated, "NCC is pleased to announce this important partnership with BD on World Cancer Day.  Our organization has a vision and commitment to eradicate cervical cancer in this high-risk region of Latin America, and we are pleased with BD's strong commitment and generous support of our efforts."  Landry added, "NCC's goal is to reverse the increasing incidence and mortality rates of cervical cancer, so that women can be free of this devastating disease in the future.  NCC seeks to transform how cervical cancer is addressed through our comprehensive woman's cancer initiatives."  The NCC Cervical Cancer Program has delivered access to training, diagnostic equipment, preventative therapies and treatment for at-risk women, as well as for the medical institutes that treat them in Latin America and Africa.

"Cervical cancer is deadly, especially for women who live in remote areas without access to today's liquid-based cytology screening methods," said Wayne Brinster, Vice President and General Manager, Women's Health and Cancer, BD Diagnostics.  "That is why BD is pleased to work with the National Cancer Coalition to help women in this underserved region benefit from a proven technology, which is often taken for granted in developed countries."  

BD is committing over $1 million in support to this NCC initiative over a three year period, which includes donations of: the BD SurePath™ Pap technology, corresponding consumables, services, technical expertise, and $150,000 in financial support.  This donation to NCC marks the largest ever in the field of cancer by BD, a company with significant expertise in women's health and cancer.

This program will be implemented by NCC in partnership with its local partner in Cusco – the CerviCusco Clinic.  CerviCusco was founded and is lead by Daron G. Ferris, MD, an internationally respected expert in cervical cancer prevention and detection.  Dr. Ferris stated, "through this collaboration with NCC, the CerviCusco clinic is pleased to have the opportunity to significantly increase the number of Pap tests that we administer annually for underserved women in the Cusco region.  This new support by BD is significant and will draw much needed attention for comprehensive strategies against cervical cancer – a leading killer of women in the developing world that is preventable through HPV vaccination or treatable when found by early detection methods.  We salute NCC and BD for making this impressive commitment in the global fight against cervical cancer."  

Source:

National Cancer Coalition

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BD (Becton, Dickinson and Company). (2019, June 19). NCC, BD to implement cervical cancer early detection program for underserved women in Peru. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20110205/NCC-BD-to-implement-cervical-cancer-early-detection-program-for-underserved-women-in-Peru.aspx.

  • MLA

    BD (Becton, Dickinson and Company). "NCC, BD to implement cervical cancer early detection program for underserved women in Peru". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20110205/NCC-BD-to-implement-cervical-cancer-early-detection-program-for-underserved-women-in-Peru.aspx>.

  • Chicago

    BD (Becton, Dickinson and Company). "NCC, BD to implement cervical cancer early detection program for underserved women in Peru". News-Medical. https://www.news-medical.net/news/20110205/NCC-BD-to-implement-cervical-cancer-early-detection-program-for-underserved-women-in-Peru.aspx. (accessed December 22, 2024).

  • Harvard

    BD (Becton, Dickinson and Company). 2019. NCC, BD to implement cervical cancer early detection program for underserved women in Peru. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20110205/NCC-BD-to-implement-cervical-cancer-early-detection-program-for-underserved-women-in-Peru.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New BD MAX Check-Points CPO assay receives FDA 510(k) clearance